These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 16908914)

  • 1. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.
    Shlipak MG; Katz R; Sarnak MJ; Fried LF; Newman AB; Stehman-Breen C; Seliger SL; Kestenbaum B; Psaty B; Tracy RP; Siscovick DS
    Ann Intern Med; 2006 Aug; 145(4):237-46. PubMed ID: 16908914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C as a risk factor for outcomes in chronic kidney disease.
    Menon V; Shlipak MG; Wang X; Coresh J; Greene T; Stevens L; Kusek JW; Beck GJ; Collins AJ; Levey AS; Sarnak MJ
    Ann Intern Med; 2007 Jul; 147(1):19-27. PubMed ID: 17606957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.
    Deo R; Fyr CL; Fried LF; Newman AB; Harris TB; Angleman S; Green C; Kritchevsky SB; Chertow GM; Cummings SR; Shlipak MG;
    Am Heart J; 2008 Jan; 155(1):62-8. PubMed ID: 18082491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C concentration as a risk factor for heart failure in older adults.
    Sarnak MJ; Katz R; Stehman-Breen CO; Fried LF; Jenny NS; Psaty BM; Newman AB; Siscovick D; Shlipak MG;
    Ann Intern Med; 2005 Apr; 142(7):497-505. PubMed ID: 15809461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
    Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.
    Stevens LA; Coresh J; Schmid CH; Feldman HI; Froissart M; Kusek J; Rossert J; Van Lente F; Bruce RD; Zhang YL; Greene T; Levey AS
    Am J Kidney Dis; 2008 Mar; 51(3):395-406. PubMed ID: 18295055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C and the risk of death and cardiovascular events among elderly persons.
    Shlipak MG; Sarnak MJ; Katz R; Fried LF; Seliger SL; Newman AB; Siscovick DS; Stehman-Breen C
    N Engl J Med; 2005 May; 352(20):2049-60. PubMed ID: 15901858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.
    Ix JH; Shlipak MG; Chertow GM; Whooley MA
    Circulation; 2007 Jan; 115(2):173-9. PubMed ID: 17190862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    He J; Shlipak M; Anderson A; Roy JA; Feldman HI; Kallem RR; Kanthety R; Kusek JW; Ojo A; Rahman M; Ricardo AC; Soliman EZ; Wolf M; Zhang X; Raj D; Hamm L;
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Clin Nephrol; 2008 Jul; 70(1):10-7. PubMed ID: 18793543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.
    Peralta CA; Shlipak MG; Judd S; Cushman M; McClellan W; Zakai NA; Safford MM; Zhang X; Muntner P; Warnock D
    JAMA; 2011 Apr; 305(15):1545-52. PubMed ID: 21482744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C as a predictor of mortality in elderly patients with chronic kidney disease.
    Bevc S; Hojs N; Knehtl M; Ekart R; Hojs R
    Aging Male; 2019 Mar; 22(1):62-67. PubMed ID: 29912597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
    ; Grams ME; Coresh J; Matsushita K; Ballew SH; Sang Y; Surapaneni A; Alencar de Pinho N; Anderson A; Appel LJ; Ärnlöv J; Azizi F; Bansal N; Bell S; Bilo HJG; Brunskill NJ; Carrero JJ; Chadban S; Chalmers J; Chen J; Ciemins E; Cirillo M; Ebert N; Evans M; Ferreiro A; Fu EL; Fukagawa M; Green JA; Gutierrez OM; Herrington WG; Hwang SJ; Inker LA; Iseki K; Jafar T; Jassal SK; Jha V; Kadota A; Katz R; Köttgen A; Konta T; Kronenberg F; Lee BJ; Lees J; Levin A; Looker HC; Major R; Melzer Cohen C; Mieno M; Miyazaki M; Moranne O; Muraki I; Naimark D; Nitsch D; Oh W; Pena M; Purnell TS; Sabanayagam C; Satoh M; Sawhney S; Schaeffner E; Schöttker B; Shen JI; Shlipak MG; Sinha S; Stengel B; Sumida K; Tonelli M; Valdivielso JM; van Zuilen AD; Visseren FLJ; Wang AY; Wen CP; Wheeler DC; Yatsuya H; Yamagata K; Yang JW; Young A; Zhang H; Zhang L; Levey AS; Gansevoort RT
    JAMA; 2023 Oct; 330(13):1266-1277. PubMed ID: 37787795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of kidney function and prediction of death from cardiovascular and other causes in the elderly: A 9-year follow-up study.
    Salminen M; Laine K; Korhonen P; Wasen E; Vahlberg T; Isoaho R; Kivelä SL; Löppönen M; Irjala K
    Eur J Intern Med; 2016 Sep; 33():98-101. PubMed ID: 27370901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased kidney function in the elderly: clinical and preclinical, neither benign.
    Coresh J; Astor B
    Ann Intern Med; 2006 Aug; 145(4):299-301. PubMed ID: 16908921
    [No Abstract]   [Full Text] [Related]  

  • 17. Kidney function as a predictor of noncardiovascular mortality.
    Fried LF; Katz R; Sarnak MJ; Shlipak MG; Chaves PH; Jenny NS; Stehman-Breen C; Gillen D; Bleyer AJ; Hirsch C; Siscovick D; Newman AB
    J Am Soc Nephrol; 2005 Dec; 16(12):3728-35. PubMed ID: 16251239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods.
    White C; Akbari A; Hussain N; Dinh L; Filler G; Lepage N; Knoll GA
    J Am Soc Nephrol; 2005 Dec; 16(12):3763-70. PubMed ID: 16236805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank.
    Chen DC; Lees JS; Lu K; Scherzer R; Rutherford E; Mark PB; Kanaya AM; Shlipak MG; Estrella MM
    J Am Heart Assoc; 2023 Feb; 12(3):e027079. PubMed ID: 36695320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships of Measured Iohexol GFR and Estimated GFR With CKD-Related Biomarkers in Children and Adolescents.
    Ng DK; Schwartz GJ; Warady BA; Furth SL; Muñoz A
    Am J Kidney Dis; 2017 Sep; 70(3):397-405. PubMed ID: 28549535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.